Hosted on MSN

Vapor reacts #1021 | FNAF 6 Minecraft animation "Break the cycle" by EnchantedMob reaction!

The dollar is sinking. Trump thinks it’s great. A Massive New Study of 20,000 Adults Says This Is What Happens When You Start Going to Bed Early Kurt Russell on set of his Michelob Ultra Super Bowl ad ...
Nasdaq

ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lung Cancer

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA (nogapendekin alfa inbakicept) ...
EurekAlert!

Centromere protein I, a cell cycle checkpoint gene, accelerates tumor progression via the hippo pathway and mediates immune escape in hepatocellular carcinoma

This study presents a comprehensive investigation into the prognostic significance of CCCRGs in HCC. Notably, our research provides the first mechanistic evidence that CENPI promotes HCC malignant ...
Hosted on MSN

Timing of immune checkpoint inhibitor administration affects small cell lung cancer survival

MONDAY, Dec. 8, 2025 (HealthDay News) -- For patients with extensive-stage small cell lung cancer (ES-SCLC), administration of immune checkpoint inhibitor (ICI) therapy earlier in the day is ...
GamesRadar+

Splinter Cell: Deathwatch review: "A pale imitation of the long-dormant stealth franchise"

Splinter Cell: Deathwatch brings Sam Fisher out of retirement for one final mission, but maybe it shouldn't have bothered. While it occasionally sparks into life in the final act (with Liev Schreiber ...
BioSpace

BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor Failure

In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated an overall response rate (ORR) of 23% and a disease control ...
EurekAlert!

Targeting cell cycle regulators: a new paradigm in cancer therapeutics

The review emphasizes how breakthroughs in understanding the molecular mechanisms of cell cycle regulation have paved the way for the development of targeted anti-cancer agents. Notably, inhibitors of ...
Nasdaq

Checkpoint Therapeutics, Inc. Announces FDA Approval of UNLOXCYT™ for Advanced Cutaneous Squamous Cell Carcinoma and Upcoming Merger Vote

Checkpoint Therapeutics, Inc. announced that the U.S. FDA approved its drug UNLOXCYT™ (cosibelimab-ipdl) in December 2024, making it the first and only anti-PD-L1 treatment for adults with advanced ...
News Medical

PD-1 deficiency reveals the impact of checkpoint inhibition on B cell function

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...
FierceBiotech

Immatics' cell therapy leapfrogs into phase 3 on strength of early-stage survival data

Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of its melanoma cell therapy IMA203 this year in light of the response and ...
Business Wire

ImmunityBio Presents Positive Long-Term Overall Survival Data in Non-Small Cell Lung Cancer Patients and Announces Registrational Intent Phase 3 Trials with ANKTIVA ® and ...

CULVER CITY, Calif.--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), today announced positive results from its QUILT 3.055 trial demonstrating long-term extended survival of ...